Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet
Publication

Publications

Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet

Title
Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet
Type
Article in International Scientific Journal
Year
2021
Authors
Pereira, LAL
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Meng, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Amoedo, MAG
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Mendes, MTdSCPF
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Marques, MAMP
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
João Frazão
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Weigert, ALL
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: NefrologiaImported from Authenticus Search for Journal Publications
ISSN: 0211-6995
Other information
Authenticus ID: P-00V-ZCJ
Resumo (PT):
Abstract (EN):
Language: English
Type (Professor's evaluation): Dissemination
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet [Etelcalcetida controla el hiperparatiroidismo secundario y eleva los niveles de esclerostina en pacientes en hemodiálisis previamente no controlados con cinacalcet] (2022)
Article in International Scientific Journal
Pereira, LAL; Meng, C; Amoedo, MAG; Mendes, MTDSCPF; Marques, MAMP; João Frazão; Weigert, ALL

Of the same journal

Clinical value of natriuretic peptides in chronic kidney disease (2015)
Another Publication in an International Scientific Journal
Santos Araujo, C; Leite-Moreira AF; Pestana M
Clinical value of natriuretic peptides in chronic kidney disease (2015)
Another Publication in an International Scientific Journal
Santos Araújo, C; Leite-Moreira AF; Pestana M
Vascular calcification in peritoneal dialysis patients and its association with bone-derived molecules and bone histomorphometry (2024)
Article in International Scientific Journal
Pereira, L; Mendonça, Luís; Magalhaes, J; Ricardo Neto; Quelhas-Santos, J; Oliveira, A; Beco, A; João Frazão
The role of Fibroblast Growth Factor 23 in chronic kidney disease-mineral and bone disorder (2013)
Article in International Scientific Journal
Diniz, H; João Frazão
Renal manifestations in adults with mitochondrial disease from the mtDNA m.3243A>G pathogenic variant (2023)
Article in International Scientific Journal
Ferreira, F; Bacelar, CG; Lisboa-Gonçalves, P; Paulo, N; Quental, R; Nunes, AT; Silva, R; Tavares, I

See all (11)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-23 at 14:02:21 | Privacy Policy | Personal Data Protection Policy | Whistleblowing